Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9604 posts found.

news

Free Webinar: EudraVigilance changes and the impact on MAHs

October 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, eudravigilance, pharma, pharmaceutical, primevigilance

Following on from the popularity of our previous free webinar sessions, Pharmafocus is once again partnering with PrimeVigilance to bring you an overview of the EudraVigilance changes and their impact on MAHs.
News
microscope-275984_960_720

First leprosy vaccine makes initial step towards human use

October 13, 2017 Medical Communications, Research and Development biotech, drugs, leprosy, pharma, pharmaceutical

A vaccine for leprosy, developed by the Infectious Disease Research Institute (IDRI) and with the financial support of the American …
News
shutterstock_95714119

Strong IBS and constipation Phase 3 data sends Ardelyx shares rocketing 60%

October 12, 2017 Research and Development Ardelyx, pharma, pharmaceuticals, tenapanor

Ardelyx has confirmed that its NHE3 inhibitor tenapanor met all its primary and secondary endpoints in the study of its …
News
weight-2036971_960_720

Childhood obesity increased 10-fold over last four decades

October 11, 2017 Research and Development biotech, drugs, obese, obesity, pharma, pharmaceutical

An analysis of childhood and teenage obesity levels around the world have revealed that the numbers who are considered dangerously …
News
shutterstock_254160583

Lupin scoops up women’s health specialist Symbiomix for $150 million

October 11, 2017 Research and Development, Sales and Marketing India, Lupin, Lupin Pharmaceuticals, Symbiomix, US, acquisition, pharma

The US arm of Mumbai’s Lupin Pharmaceuticals has announced that it is has acquired US-based gynaecologic treatment specialist Symbiomix Therapeutics …
News
shutterstock_212432119

Moffitt scientists discover new applications for Novartis’s Zykadia

October 11, 2017 Research and Development Cancer, Moffitt, NSCLC, ceritinib, lung cancer, zykadia

Through the use of molecular screening, functional proteomics and computer-based modelling, researchers from the Moffitt Cancer Center have been working …
News
biocon-ltd-hebbagodi-bangalore-ukif4_web

Mylan and Biocon Neulasta biosimilar knocked back by FDA

October 11, 2017 Research and Development, Sales and Marketing Amgen, Biocon, Mylan, Neulasta, biotech, drugs, pharma, pharmaceutical

Mylan and Biocon’s biosimilar version of Amgen’s blockbuster, Neulasta (pegfilgrastim), will have to wait a bit longer before getting the …
News
allergan

Allergan settles gender discrimination case for $4m

October 11, 2017 Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

It could have been much worse for Allergan, after it agreed to pay $4 million to resolve a lawsuit alleging …
News
david-crossman300_web

NHS Scotland appoints new Chief Scientist

October 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Scotland, biotech, drugs, pharma, pharmaceutical

NHS Scotland has revealed the appointment of Professor David Crossman as its new Chief Scientist, after advertising externally to fill …
Appointment
fire-166421_960_720

Use of antacids found to promote liver disease

October 10, 2017 Manufacturing and Production, Research and Development biotech, drugs, liver disease, pharma, pharmaceutical

A study emerging from the University of California, San Diego, has revealed a correlation between the use of common acid …
News
shutterstock_360472550

Harnessing the power of the immune system

October 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, immunotherapy, pharma, pharmaceuticals

Dr Áine McCarthy, Senior Science Information Officer at Cancer Research UK, discusses the latest efforts to further understand the immunotherapies …
Feature
800px-flag_of_the_peoples_republic_of_china

China to accelerate drug approvals with overseas trial data

October 9, 2017 Research and Development, Sales and Marketing China, drug approvals, pharma, pharmaceuticals

In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from …
News

Sanofi promotes global head of diabetes to expand role

October 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, biotech, diabetes, drugs, pharma, pharmaceutical

Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

October 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The week has flown by and was packed with a number of shocking stories. With the ongoing uncertainty regarding Brexit, …
News
bayer_cross_2

Bayer forced to halt huge study into key drug

October 6, 2017 Medical Communications, Research and Development Bayer, Janssen, Xarelto, biotech, drugs, pharma, pharmaceutical

Bayer, and development partner Janssen, have been forced to stop a Phase 3 trial looking at expanding the indication of …
News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026